Average Co-Inventor Count = 9.68
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (26 from 822 patents)
2. Abbott Laboratories Corporation (7 from 4,179 patents)
3. Genentech, Inc. (3 from 3,223 patents)
4. Walter and Eliza Hall Institute of Medical Research (3 from 80 patents)
5. Abbvie Bahamas Limited (6 patents)
33 patents:
1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
2. 10633379 - Bromodomain inhibitors
3. 10131657 - Bromodomain inhibitors
4. 10035800 - Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
5. 9957263 - Bromodomain inhibitors
6. 9776990 - Isoindolone derivatives
7. 9493411 - Pyrrole-3-carboxamide bromodomain inhibitors
8. 9359296 - 7-substituted indole Mcl-1 inhibitors
9. 9321764 - Dihydro-pyrrolopyridinone inhibitors
10. 9315488 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
11. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12. 9296741 - Bromodomain inhibitors
13. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
14. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
15. 9073855 - BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases